Leeward Investments LLC MA Acquires New Holdings in Agilent Technologies, Inc. $A

Leeward Investments LLC MA acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 90,754 shares of the medical research company’s stock, valued at approximately $12,349,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Board of the Pension Protection Fund bought a new stake in shares of Agilent Technologies during the fourth quarter valued at about $27,000. Navalign LLC bought a new stake in shares of Agilent Technologies during the fourth quarter valued at about $27,000. Physician Wealth Advisors Inc. raised its stake in shares of Agilent Technologies by 490.0% during the third quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock valued at $30,000 after purchasing an additional 196 shares in the last quarter. Torren Management LLC acquired a new position in Agilent Technologies during the fourth quarter worth about $32,000. Finally, State of Wyoming acquired a new position in Agilent Technologies during the second quarter worth about $35,000.

Wall Street Analysts Forecast Growth

A has been the topic of a number of research analyst reports. Barclays lowered their target price on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Wells Fargo & Company lowered their target price on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a report on Thursday, February 26th. TD Cowen lowered their target price on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. HSBC initiated coverage on Agilent Technologies in a report on Tuesday, January 20th. They set a “buy” rating and a $180.00 target price on the stock. Finally, UBS Group lowered their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $163.71.

Agilent Technologies Price Performance

NYSE:A opened at $113.23 on Friday. The business’s 50-day moving average price is $115.24 and its 200 day moving average price is $130.81. The firm has a market cap of $32.00 billion, a P/E ratio of 24.99, a PEG ratio of 2.37 and a beta of 1.22. Agilent Technologies, Inc. has a 52-week low of $107.07 and a 52-week high of $160.27. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). The company had revenue of $1.80 billion during the quarter, compared to analysts’ expectations of $1.81 billion. Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, sell-side analysts predict that Agilent Technologies, Inc. will post 5.95 earnings per share for the current fiscal year.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.